Abivax S.A. (ABVX)
Pharmaceutical Preparations
Latest Price
$113.58
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
88.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 6.01M | $800.0M | 8.64% | -473.3K | 2026-06-30 |
| CITADEL ADVISORS LLC | 4.24M | $565.0M | 6.10% | +2.90M | 2026-06-30 |
| Darwin Global Management, Ltd. | 3.62M | $348.0M | 5.21% | +152.9K | 2026-06-30 |
| Helikon Investments Ltd | 2.79M | $371.0M | 4.01% | +1.77M | 2026-06-30 |
| Vestal Point Capital, LP | 2.35M | $313.0M | 3.38% | +849.4K | 2026-06-30 |
| Jupiter Topco LLC | 1.91M | $255.0M | 2.75% | -- | 2026-06-30 |
| UBS Group AG | 1.86M | $247.0M | 2.68% | -2.69M | 2026-06-30 |
| ADAR1 Capital Management, LLC | 1.85M | $246.0M | 2.66% | +411.1K | 2026-06-30 |
| Caligan Partners LP | 1.56M | $207.0M | 2.24% | +96.0K | 2026-06-30 |
| MORGAN STANLEY | 1.43M | $190.0M | 2.06% | -272.8K | 2026-06-30 |